According to the World Health Organization approximately 25 million people have cancer in Japan, Europe and North America. Every year more than 7.6 million people die from cancer and 12 million new cases are diagnosed.

The biomarker family measuring thymidine kinase (TK 210) that is being developed by AroCell is a group of markers for cell growth based on the protein thymidine kinase (TK). TK is the only marker for cell growth that can be measured directly in a blood sample.